A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Allergan315 enrolled

Overview

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Study Type

OBSERVATIONAL

Enrollment

315

Conditions

Glaucoma, Open-Angle

Interventions

Standard of CareOTHER

Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Glaucoma in one or both eyes Exclusion Criteria: * Participation in a glaucoma therapeutic clinical trial

Locations (1)

Unnamed facility

Barcelona, Spain

Outcomes

Primary Outcomes

Change from Baseline in Visual Field

Time frame: Baseline, 24 Months

Secondary Outcomes

Change from Baseline in Intraocular Pressure (IOP)

Time frame: Baseline, 24 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.